Astera Labs (NASDAQ:ALAB – Get Free Report) released its earnings results on Tuesday. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11, FiscalAI reports. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs updated its Q3 2026 guidance to 1.160-1.210 EPS.
Here are the key takeaways from Astera Labs’ conference call:
- Record Q2 revenue reached $392.4 million, up 27% sequentially and 104% year over year, with broad-based strength across AI fabric and signal-conditioning products. Non-GAAP operating margin expanded to 39.1% and diluted EPS rose to $0.80.
- Management expects Q3 revenue of $540 million to $560 million, representing approximately 40% sequential growth at the midpoint, driven by the Scorpio X-Series volume ramp, PCIe 6.0 Aries demand, and early Taurus 800G shipments. Scorpio is expected to become the company’s largest product family in Q3.
- Scorpio X-Series is entering high-volume production with the lead customer, while more than 10 customers are engaged across production, pre-production, or qualification programs. Management said the platform could eventually deliver more than $1,000 of content per accelerator, supported by higher-radix switching, software-enabled in-network compute, and HyperCast features.
- Astera highlighted several longer-term growth opportunities, including UALink, CXL memory connectivity, optical interconnects, and custom silicon. Initial optical deployments are targeted for 2027, CPO products for 2028 and beyond, and custom CXL and connectivity design wins are expected to begin shipping in 2027.
- Q3 non-GAAP gross margin is expected to decline to approximately 72% from 73.7% in Q2 as product mix broadens toward switching and module-related revenue. Management expects margins to trend toward a long-term target of roughly 70% despite continued operating leverage.
Astera Labs Stock Performance
ALAB stock traded up $40.62 during mid-day trading on Tuesday, hitting $361.67. 10,002,005 shares of the company were exchanged, compared to its average volume of 4,428,536. The firm has a market cap of $61.99 billion, a P/E ratio of 237.82, a P/E/G ratio of 3.72 and a beta of 3.84. The firm’s 50 day simple moving average is $361.12 and its 200 day simple moving average is $232.51. Astera Labs has a 1-year low of $97.89 and a 1-year high of $499.48.
Insider Activity
Institutional Trading of Astera Labs
Hedge funds and other institutional investors have recently modified their holdings of the company. Amundi lifted its holdings in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. State Street Corp grew its position in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Astera Labs by 162.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,164,414 shares of the company’s stock worth $193,713,000 after purchasing an additional 720,844 shares during the period. Voloridge Investment Management LLC acquired a new stake in Astera Labs during the 3rd quarter worth approximately $131,539,000. Finally, Holocene Advisors LP acquired a new stake in Astera Labs during the 2nd quarter worth approximately $55,827,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Q2 earnings and revenue beat expectations. Astera Labs reported adjusted earnings of $0.80 per share, above the $0.69 consensus estimate and up from $0.44 a year earlier. Revenue reached a record $392.4 million, exceeding the $360.85 million estimate and increasing 104.5% year over year. Astera Labs Beats Q2 Earnings and Revenue Estimates
- Positive Sentiment: Q3 guidance was well above analyst forecasts. Management projected earnings of $1.16-$1.21 per share and revenue of $540 million-$560 million, compared with consensus estimates of $0.73 per share and $410.3 million in revenue. The outlook implies another sharp acceleration in growth. Astera Labs Reports Second Quarter 2026 Financial Results
- Positive Sentiment: New product ramp is expected to drive the acceleration. Astera Labs said Q3 growth will be supported by production ramp-up of its Scorpio X-Series 320-lane fabric switch, alongside diversified demand across AI fabrics and signal-conditioning products. Astera Labs Stock Shoots Higher After Q2 Earnings
- Neutral Sentiment: Investor expectations were already elevated. Recent coverage highlighted optimism surrounding Astera Labs’ Amazon partnership and AI infrastructure exposure, helping the stock advance ahead of earnings. Its high valuation and volatility mean additional upside may depend on continued results that exceed expectations. Astera Labs Benefits From Amazon Partnership
- Negative Sentiment: One analyst target remains below the current market level. A previously reported price-target increase to $275 suggests some valuation caution, although that target predates the latest earnings report and guidance. Astera Labs Price Target Raised to $275
Analyst Ratings Changes
A number of brokerages have recently commented on ALAB. Evercore reaffirmed an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. JPMorgan Chase & Co. boosted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. UBS Group upped their target price on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th. Finally, Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $289.00.
Read Our Latest Analysis on Astera Labs
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
